Home » Stephanie Hedt

About Stephanie Hedt

Stephanie Hedt is the Policy Communications Editor at the USC Schaeffer Center for Health Policy & Economics. More information about Stephanie can be found here.

Articles

The Essential Scan: Top Findings in Health Policy Research | Edition 28

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers.

(more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 27

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers.

(more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 26

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers.

(more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 25

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers. (more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 24

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers.

(more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 23

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers. (more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 20

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers. (more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 19

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers. (more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 18

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers. (more…)

The Essential Scan: Top Findings in Health Policy Research | Edition 17

What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers. (more…)

Measuring Value in Clinical Trials: Patient Preference Doesn’t Equal Average Survival

Though clinical trials most often rely on average survival rates as measures of value, these are not synonymous indicators. New research by the Schaeffer Center finds additional factors may weigh in patient’s treatment choice.  (more…)

Schaeffer Center Experts Quoted in Multiple New York Times Articles this Week

Research conducted by the Schaeffer Center has salience in the media (more…)

The Baby Boomers Will Shift the Health Status of the Medicare Population

A Typical Medicare Recipient in 2030

A new study by Schaeffer Center researchers Etienne Gaudette, Bryan Tysinger, and Dana Goldman predicts significant changes in the average future Medicare recipient. (more…)

A New Line of Specialty Drugs: PCSK9 Inhibitors (Part 2)

This fall, a new line of specialty drugs will hit the market- PCSK9 inhibitors.  PCSK9 inhibitors are a new class of drugs used to lower LDL (bad) cholesterol levels through stifling a protein (PCSK9). The drug is injected once or twice a month and is (more…)

What’s a Fair Price? The Debate Over Value & Cost of Specialty Drugs (Part 1)

When Turing Pharmaceuticals raised the price of a drug that had been on the market for over 60 years from $13 to $750 a pill there was overwhelming public dismay.  For many, it highlighted the growing concern over prescription drug prices.   (more…)

Students Engage in Health Policy Research for Schaeffer Center’s Summer Internship Program

The Schaeffer Center’s 2nd Annual Summer Internship Program draws to a close as the nine student interns, working with faculty mentors, presented the findings of their independent research projects. Student research ranged from an (more…)

When is the Cost of Care Worth it?

New medical technologies to treat chronic disease are typically accompanied by increases in both health care costs and health outcomes: while treatment costs have continuously increased over the years, the value of those treatments have not always shown the same growth in measured benefits. This disconnect influences (more…)

The US Hospital System May Be Outperforming Expectations

In a new Health Affairs article released in February, Schaeffer Center researchers provide evidence that hospital productivity increased from 2002 to 2011, suggesting that the US health care system could be performing better than many believe.  John Romley, Research Assistant Professor at the USC Schaeffer Center for Health (more…)

Benefits of Robotic-Assisted Surgery for Kidney Cancer Far Outweigh Investment Costs

The benefits of robotically-assisted surgery for patients with kidney cancer outweigh the healthcare and surgical costs by a ratio of five to one. This is according to new research published in Health Affairs(more…)

Five Myths About Cancer Care in America

One of the most pervasive and misguided myths about cancer is that the ‘war on cancer’ has been a failure. With provocative news headlines about cancer often popping up, it is understandable that there is public uncertainty about progress in its treatment and patient care. (more…)

Follow CESR on Facebook



Follow Schaeffer on Facebook